Aberrant nuclear accumulation of glycogen synthase kinase-3β in human pancreatic cancer: Association with kinase activity and tumor dedifferentiation

Clinical Cancer Research

Volumn 12, Issue 17, 2006, Pages 5074-5081

  Ougolkov, Andrei V ^a   Fernandez Zapico, Martin E ^a   Bilim, Vladimir N ^c   Smyrk, Thomas C ^a   Chari, Suresh T ^b   Billadeau, Daniel D ^a,d  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c YAMAGATA UNIVERSITY   (Japan)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; IN VIVO STUDY; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NF-KAPPA B; PANCREATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; SURVIVAL RATE; THIAZOLES; TRANSPLANTATION, HETEROLOGOUS; UREA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33749015218     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0196     Document Type: Article

References (25)

1. Wang W, Abbruzzese JL, Evans DB, Larry U, Cleary KR, Chiao PJ. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119-27.
2. Aggarwal BB. Nuclear factor-κB: the enemy within. Cancer Cell 2004;6:203-8.
3. Wang CY, Cusack JC, Jr., Liu R, Baldwin AS, Jr. Control of inducible chemoresistance: enhanced antitumor therapy through increased apoptosis by inhibition of NF-κB. Nat Med 1999;5:412-7.
4. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1992;1114:147-62.
5. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003;116:1175-86.
6. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995;376:167-70.
7. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999;284:321-5.
8. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 2000;406:86-90.
9. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD. Glycogen synthase kinase-3β participates in nuclear factor-κB- mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 2005;65:2076-81.
10. Bhat R, Xue Y, Berg S, et al. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem 2003;278:45937-45.
11. Dignam JD, Lebovitz RM, Boeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-89.
12. Ougolkov A, Zhang B, Yamashita K, et al. Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer. J Natl Cancer Inst 2004;96:1161-70.
13. Tornusciolo DR, Schmidt RE, Roth KA. Simultaneous detection of TDT-mediated dUTP-biotin nick end-labeling (TUNEL)-positive cells and multiple immunohistochemical markers in single tissue sections. Biotechniques 1995;19:800-5.
14. Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, et al. Ectopic expression of Vav1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 2005;7:39-49.
15. Beals CR, Sheridan CM, Turck, CW, Gardner P, Crabtree GR. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997;275:1930-4.
16. Wei W, Jin J, Schlisio S, Harper JW, Kaelin WG, Jr. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 2005;8:25-33.
17. Liu S, Yu S, Hasegawa Y, et al. Glycogen synthase kinase 3β is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase. J Biol Chem 2004;279:51075-81.
18. Shakoori A, Ougolkov A, Yu ZW, et al. Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun 2005;334:1365-74.
19. Mazor M, Kawano Y, Zhu H, Waxman J, Kypta RM. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene 2004;23:7882-92.
20. Erdal E, Ozturk N, Cagatay T, Eksioglu-Demiralp E, Ozturk M. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. Int J Cancer 2005;115:903-10.
21. DeToni F, Racaud-Sultan C, Chicanne G, et al. A cross-talk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 2006;25:3113-22.
22. Rask K, Nilsson A, Brannstrom M, et al. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β. Br J Cancer 2003;89:1298-304.
23. Gotoh J, Obata M, Yoshie M, Kasai S, Ogawa K. Cyclin D1 overexpression correlates with β-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3β, and ERK1/2 in mouse hepatic carcinogenesis. Carcinogenesis 2003;24:435-42.
24. Steinbrecher KA, Wilson W III, Cogswell PC, Baldwin AS. Glycogen Synthase Kinase 3{β} Functions To Specify Gene-Specific, NF-{κ}B-Dependent Transcription. Mol Cell Biol 2005;25:8444-55.
25. Schwabe RF, Brenner DA. Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes. Am J Physiol Gastrointest Liver Physiol 2002;283:G204-11.